$Zomedica Pharmaceuticals Corp

Believe in what you invest in...

“Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2020 of approximately $16.9 million or $0.05 per share, compared to a loss of approximately $19.8 million or $0.19 per share for the year ended December 31, 2019”.

This stock didn’t have any revenue in 2020 but they still managed to beat 2019 loss? Why? They did well on research and investing. Now that they’re releasing TRUFORMA changes the tide in the market.

Veterinary Diagnostics is a growing market and I see ZOM being one of the biggest competitor with their product. Why?

· Enhanced capability to detect the frequency of occurrence and severity of diseases and conditions that impact companion animals;

· Increased accuracy and faster means to obtain test results;

· Wider availability of new diagnostic tools; and

· Enhanced economic benefits for veterinarians

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

SKTEE
2021-02-27
SKTEE
算是好消息吗？ [疑问]
- SKTEEReply以诚待人_3873:
  [强] [强]
- 以诚待人_3873:
  不是好消息尾盘不会涨6%
PYthon888
2021-02-27
PYthon888
是好消息。

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":366375831,"tweetId":"366375831","gmtCreate":1614401782023,"gmtModify":1704771588229,"author":{"id":3575976381024841,"authorId":3575976381024841,"authorIdStr":"3575976381024841","name":"PYthon888","avatar":"https://community-static.tradeup.com/news/cae73b820dbcc210349073fde9936aae","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"60.39%","individualDisplayEnabled":0},"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Believe in what you invest in...“Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2020 of approximately $16.9 million or $0.05 per share, compared to a loss of approximately $19.8 million or $0.19 per share for the year ended December 31, 2019”.This stock didn’t have any revenue in 2020 but they still managed to beat 2019 loss? Why? They did well on research and investing. Now that they’re releasing TRUFORMA changes the tide in the market. Veterinary Diagnostics is a growing market and I see ZOM being one of the biggest competitor with their product. Why? · Enhanced capability to detect the frequency of occurrence and severity of diseases and conditions that impact companion animals; · Increased accuracy and faster means to obtain test results; · Wider availability of new diagnostic tools; and · Enhanced economic benefits for veterinarians</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Believe in what you invest in...“Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2020 of approximately $16.9 million or $0.05 per share, compared to a loss of approximately $19.8 million or $0.19 per share for the year ended December 31, 2019”.This stock didn’t have any revenue in 2020 but they still managed to beat 2019 loss? Why? They did well on research and investing. Now that they’re releasing TRUFORMA changes the tide in the market. Veterinary Diagnostics is a growing market and I see ZOM being one of the biggest competitor with their product. Why? · Enhanced capability to detect the frequency of occurrence and severity of diseases and conditions that impact companion animals; · Increased accuracy and faster means to obtain test results; · Wider availability of new diagnostic tools; and · Enhanced economic benefits for veterinarians</body></html>","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$ Believe in what you invest in... “Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2020 of approximately $16.9 million or $0.05 per share, compared to a loss of approximately $19.8 million or $0.19 per share for the year ended December 31, 2019”. This stock didn’t have any revenue in 2020 but they still managed to beat 2019 loss? Why? They did well on research and investing. Now that they’re releasing TRUFORMA changes the tide in the market. Veterinary Diagnostics is a growing market and I see ZOM being one of the biggest competitor with their product. Why? · Enhanced capability to detect the frequency of occurrence and severity of diseases and conditions that impact companion animals; · Increased accuracy and faster means to obtain test results; · Wider availability of new diagnostic tools; and · Enhanced economic benefits for veterinarians","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/366375831","repostId":0,"isVote":1,"tweetType":1,"viewCount":2067,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ZOM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":777,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":3678051,"gmtCreate":1614408624330,"gmtModify":1680778571754,"authorId":3572676435464588,"author":{"id":3572676435464588,"authorId":3572676435464588,"name":"SKTEE","avatar":"https://static.tigerbbs.com/b040a7b47dbff33c07c927727f45ca96","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.88%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":366375831,"type":1,"supId":0,"prevId":0,"content":"算是好消息吗？ [疑问]","text":"算是好消息吗？ [疑问]","html":"算是好消息吗？ [疑问]","likeSize":0,"commentSize":2,"subComments":[{"id":3679286,"gmtCreate":1614431441792,"gmtModify":1680778591636,"authorId":3572676435464588,"author":{"id":3572676435464588,"authorId":3572676435464588,"name":"SKTEE","avatar":"https://static.tigerbbs.com/b040a7b47dbff33c07c927727f45ca96","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.88%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3557387865655690,"repliedAuthor":{"id":3557387865655690,"authorId":3557387865655690,"name":"以诚待人_3873","avatar":"https://static.tigerbbs.com/8754a256fd2706f467efa7907d472416","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":366375831,"type":1,"supId":3678051,"prevId":3679032,"content":"[强] [强]","text":"[强] [强]","html":"[强] [强]"},{"id":3679032,"gmtCreate":1614427089900,"gmtModify":1680778578596,"authorId":3557387865655690,"author":{"id":3557387865655690,"authorId":3557387865655690,"name":"以诚待人_3873","avatar":"https://static.tigerbbs.com/8754a256fd2706f467efa7907d472416","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":366375831,"type":1,"supId":3678051,"prevId":0,"content":"不是好消息尾盘不会涨6%","text":"不是好消息尾盘不会涨6%","html":"不是好消息尾盘不会涨6%"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":3678087,"gmtCreate":1614409216331,"gmtModify":1680778577189,"authorId":3575976381024841,"author":{"id":3575976381024841,"authorId":3575976381024841,"name":"PYthon888","avatar":"https://community-static.tradeup.com/news/cae73b820dbcc210349073fde9936aae","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"60.39%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":366375831,"type":1,"supId":0,"prevId":0,"content":"是好消息。","text":"是好消息。","html":"是好消息。","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/366375831"}